Skip to main content
SpringerLink
Log in

Congenital Neuropathic Bladder

  • Chapter
  • First Online:
Congenital Anomalies of the Kidney and Urinary Tract

  • 995 Accesses

Abstract

This chapter discusses the most up-to-date and comprehensive approach to the child with neuropathic bladder dysfunction, from the moment the fetus is identified until the adolescent years, in order to gain first-hand knowledge of management. It describes the controversies that still exist and the reasons why the author has chosen his path of care. It tries to explain the physiology involved so the reader can appreciate the therapeutic options chosen by the author. Once the chapter is thoroughly analyzed, the reader should have the ability to decide his/her own style of management for these children based on solid foundation of information.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CIC:

Clean intermittent catheterization

DSD:

Dyssynergy

UTI:

Urinary tract infection

VUR:

Vesicoureteral reflux

References

  1. Adzick NS, Thom EA, Spong CY, Brock III JW, Burrows PK, Johnson MP, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011;364:993–1004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Koh CJ, DeFilippo RE, Borer JG, Khoshbin S, Bauer SB. Bladder and external urethral sphincter function after prenatal closure of myelomeningocele. J Urol. 2006;176:2232–6.

    Article  PubMed  Google Scholar 

  3. Lee NG, Gomez P, Uberoi V, Kokorowski PJ, Khoshbin S, Bauer SB, et al. In utero closure of myelomeningocele does not improve lower urinary tract function. J Urol. 2012;188:1567–71.

    Article  PubMed  Google Scholar 

  4. Kroovand RL, Bell W, Hart LJ, Benfeld KY. The effect of back closure on detrusor function in neonates with myelodysplasia. J Urol. 1990;144:423–5.

    CAS  PubMed  Google Scholar 

  5. Chiaramonte RM, Horowitz EM, Kaplan GA, Brock WA. Implications of hydronephrosis in newborns with myelodysplasia. J Urol. 1986;136:427–9.

    CAS  PubMed  Google Scholar 

  6. Bauer SB, Labib KB, Dieppa RA, Retik AB. Urodynamic evaluation in a boy with myelodysplasia and incontinence. Urology. 1977;10:354–62.

    Article  CAS  PubMed  Google Scholar 

  7. Bauer SB, Austin PF, Rawashdeh YF, de Jong TP, Franco I, Siggard C, et al. International Children’s Continence Society’s recommendations for initial diagnostic evaluation and follow-up in congenital neuropathic bladder and bowel dysfunction in children. Neurourol Urodyn. 2012;31:610–4.

    Article  PubMed  Google Scholar 

  8. Frimberger D, Cheng E, Kropp BP. The current management of the neurogenic bladder in children with spina bifida. Pediatr Clin North Am. 2012;59:757–67.

    Article  PubMed  Google Scholar 

  9. Joseph DB. The effect of medium-fill and slow-fill cystometry on bladder pressure in infants and children with myelodysplasia. J Urol. 1992;147:444–6.

    CAS  PubMed  Google Scholar 

  10. Blaivas JG, Labib KB, Bauer SB, Retik AB. A new approach to elec-tromyography of the external urethral sphincter. J Urol. 1977;117:773–7.

    CAS  PubMed  Google Scholar 

  11. McGuire EJ, Woodside JR, Borden TA, Weiss RM. The prognostic value of urodynamic testing in myelodysplastic patients. J Urol. 1981;126:205–9.

    CAS  PubMed  Google Scholar 

  12. Bauer SB, Hallet M, Khoshbin S, Lebowitz RL, Winston KR, Gibson S, et al. The predictive value of urodynamic evaluation in the newborn with myelodysplasia. JAMA. 1984;152:650–2.

    Article  Google Scholar 

  13. Sidi AA, Dykstra DD, Gonzalez R. The value of urodynamic testing in the management of neonates with myelodysplasia: a prospective study. J Urol. 1986;135:90–3.

    CAS  PubMed  Google Scholar 

  14. Perez LM, Khoury J, Webster GD. The value of urodynamic studies in infants less than one year old with congenital spinal dysraphism. J Urol. 1992;148:584–7.

    CAS  PubMed  Google Scholar 

  15. Teichman JMH, Scherz HC, Kim KD, Cho DH, Packer MG, Kaplan GW. An alternative approach to myelodysplasia management: aggressive observation and prompt intervention. J Urol. 1994;152:807–11.

    CAS  PubMed  Google Scholar 

  16. Hopps CV, Kropp KA. Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close followup. J Urol. 2003;169:305–8.

    Article  PubMed  Google Scholar 

  17. Snodgrass WT, Gargollo PC. Urologic care of the neurogenic bladder in children. Urol Clin North Am. 2010;37:207–14.

    Article  PubMed  Google Scholar 

  18. Bauer SB. Myelodysplasia: newborn evaluation and management. In: McLaurin RL, editor. Spina bifida: a multidisciplinary approach. New York: Praeger; 1984. p. 262–7.

    Google Scholar 

  19. Kopp C, Greenfield SP. Effects of neurogenic bladder dysfunction in utero seen in neonates with myelodysplasia. Br J Urol. 1993;71:739–42.

    Article  CAS  PubMed  Google Scholar 

  20. Wu H-Y, Baskin LS, Kogan BA. Neurogenic bladder dysfunction due to myelomeningocele: neonatal versus childhood treatment. J Urol. 1997;157:2295–7.

    Article  CAS  PubMed  Google Scholar 

  21. Kurzrock EA, Polse S. Renal deterioration in myelodysplastic children: urodynamic evaluation and clinical correlates. J Urol. 1998;159:1657–61.

    Article  CAS  PubMed  Google Scholar 

  22. Klose AG, Sackett CK, Mesrobian H-GJ. Management of children with myelodysplasia. Urologic alternatives. J Urol. 1990;144:1446–9.

    CAS  PubMed  Google Scholar 

  23. Tanaka H, Kakizaki H, Kobayashi S, Shibata T, Ameda K, Koyanagi T, et al. The relevance of urethral resistance in children with myelodysplasia: its impact on upper urinary tract deterioration and the outcome of conservative management. J Urol. 1999;161:929–32.

    Article  CAS  PubMed  Google Scholar 

  24. Joseph DB, Bauer SB, Colodny AH, Mandell J, Retik AB. Clean intermittent catheterization in infants with neurogenic bladder. Pediatrics. 1989;84:78–83.

    CAS  PubMed  Google Scholar 

  25. Kari JA, Safdar O, Jamjoom R, Anshasi W. Renal involvement in children with spina bifida. Saudi J Kidney Dis Transpl. 2009;20:102–5.

    PubMed  Google Scholar 

  26. Kaefer M, Pabby A, Kelly M, Darbey M, Bauer SB, et al. Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomeningocele. J Urol. 1999;162:1068–71.

    Article  CAS  PubMed  Google Scholar 

  27. Bauer SB. Early evaluation and management of children with spina bifida. In: King LR, editor. Urologic surgery in neonates and young infants. Philadelphia: WB Saunders; 1988. p. 252–64.

    Google Scholar 

  28. Austin PF, Bauer SB, Bower W, Chase J, Franco I, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the Standardization Committee of the International Children’s Continence Society. J Urol. 2014;191:1863–5.

    Article  PubMed  Google Scholar 

  29. Bauer SB. Neuropathic dysfunction of the lower urinary tract. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-walsh urology. 9th ed. Philadelphia: Saunders Elsevier; 2006. p. 3625–55.

    Google Scholar 

  30. van Gool JD, Dik P, de Jong TP. Bladder-sphincter dysfunction in myelomeningocele. Eur J Pediatr. 2001;160:414–20.

    Article  PubMed  Google Scholar 

  31. Bauer SB. The management of spina bifida from birth onwards. In: Whitaker RH, Woodard JR, editors. Paediatric urology. London: Butterworths; 1985. p. 87–112.

    Google Scholar 

  32. Edelstein RA, Bauer SB, Kelly MD, Darbey MM, Peters CA, Atala A, et al. The long-term urologic response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol. 1995;154:1500–4.

    Article  CAS  PubMed  Google Scholar 

  33. Dik P, van Gool JD, de Jong-de Vos van Steenwijk CC, de Jong TP. Early start therapy preserves kidney function in spina bifida patients. Eur Urol. 2006;49:908–13.

    Article  PubMed  Google Scholar 

  34. Seki N, Masuda K, Kinukawa N, Senoh K, Naito S. Risk factors for febrile urinary tract infection in children with myelodysplasia treated by clean intermittent catheterization. Int J Urol. 2004;11:973–7.

    Article  PubMed  Google Scholar 

  35. Van Gool JD, Juijten RH, Donckerwolcke RA, Kramer PP. Detrusor- sphincter dyssynergia in children with myelomeningocele: a prospective study. Z Kinderchir. 1982;37:148–51.

    Google Scholar 

  36. Stoneking BJ, Brock JW, Pope JC, Adams MC. Early evolution of bladder emptying after myelomeningocele closure. Urology. 2001;58:767–71.

    Article  CAS  PubMed  Google Scholar 

  37. Ghoniem GM, Roach MB, Lewis VH, Harmon EP. The value of leak point pressure and bladder compliance in the urodynamic evaluation of myelomeningocele patients. J Urol. 1990;144:1440–2.

    CAS  PubMed  Google Scholar 

  38. Geranoitis E, Koff SA, Enrile B. Prophylactic use of clean intermittent catheterization in treatment of infants and young children with myelomeningocele and neurogenic bladder dysfunction. J Urol. 1988;139:85–6.

    Google Scholar 

  39. Landau EH, Churchill BM, Jayanthi VR, Gilmour RF, Steckler RE, McLorie GA, et al. The sensitivity of pressure specific bladder volume versus total bladder capacity as a measure of bladder storage dysfunction. J Urol. 1994;152:1578–81.

    CAS  PubMed  Google Scholar 

  40. Kasabian NG, Bauer SB, Dyro FM, Colodny AH, Mandell J, Retik AB. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Am J Dis Child. 1992;146:840–3.

    CAS  PubMed  Google Scholar 

  41. Barbalais GA, Klauber GT, Blaivas JG. Critical evaluation of the Credé maneuver: a urodynamic study of 207 patients. J Urol. 1983;130:720–8.

    Google Scholar 

  42. Flood HD, Ritchey ML, Bloom DA, Huang C, McGuire EJ. Outcome of reflux in children with myelodysplasia managed by bladder pressure monitoring. J Urol. 1994;152:1574–7.

    CAS  PubMed  Google Scholar 

  43. Stein DR, Gordon CM, Feldman HA, Hobbs NM, Bauer SB, Baum MB. Chronic kidney disease in children with myelodysplasia/spina bifida. Poster presentation, Pediatric Academic Societies; 2011. (Abstract # 752298).

    Google Scholar 

  44. Agarwal SK, McLorie GA, Grewal D, Joyner BD, Bägli DJ, Khoury AE, et al. Urodynamic correlates of resolution of reflux meningomyelocele patients. J Urol. 1997;158:580–2.

    Article  CAS  PubMed  Google Scholar 

  45. Bauer SB, Colodny AH, Retik AB. The management of vesico-ureteral reflux in children with myelodysplasia. J Urol. 1982;128:102–5.

    CAS  PubMed  Google Scholar 

  46. Kaplan WE, Firlit CF. Management of reflux in myelodysplastic children. J Urol. 1983;129:1195–7.

    CAS  PubMed  Google Scholar 

  47. Jeffs RD, Jones P, Schillinger JF. Surgical correction of vesico-ureteral reflux in children with neurogenic bladder. J Urol. 1976;115:449–55.

    CAS  PubMed  Google Scholar 

  48. Kass EJ, Koff SA, Lapides J. Fate of vesico-ureteral reflux in children with neuropathic bladders managed by intermittent catheterization. J Urol. 1981;125:63–4.

    CAS  PubMed  Google Scholar 

  49. Schlussel R. Cystoscopic correction of reflux. Curr Urol Rep. 2004;5:127–31.

    Article  PubMed  Google Scholar 

  50. Elder JS, Diaz M, Caldamone AA, Cendron M, Greenfield S, Hurwitz R. Endoscopic therapy for vesicoureteral reflux: meta-analysis. I. Reflux resolution and urinary tract infection. J Urol. 2006;175:716–22.

    Article  PubMed  Google Scholar 

  51. Duckett JW. Cutaneous vesicostomy in childhood. Urol Clin North Am. 1974;1:485–95.

    PubMed  Google Scholar 

  52. Mandell J, Bauer SB, Colodny AH, Retik AB. Cutaneous vesicostomy in infancy. J Urol. 1981;126:92–3.

    CAS  PubMed  Google Scholar 

  53. Morrisroe SN, O’Connor RC, Nanigian DK, Kurzrock EA, Stone AR. Vesicostomy revisited: the best treatment for the hostile bladder in myelodysplastic children? BJU Int. 2005;96:397–400.

    Article  PubMed  Google Scholar 

  54. Spindel MR, Bauer SB, Dyro FM, Krarup C, Khoshbin S, Winston KR, et al. The changing neuro-urologic lesion in myelodysplasia. JAMA. 1987;258:1630–3.

    Article  CAS  PubMed  Google Scholar 

  55. Lais A, Kasabian NG, Dyro FM, Scott RM, Kelly MD, Bauer SB. Neurosurgical implications of continuous neuro-urological surveillance of children with myelodysplasia. J Urol. 1993;150:1879–83.

    CAS  PubMed  Google Scholar 

  56. Dator DP, Hatchett L, Dyro EM, Shefner JM, Bauer SB. Urodynamic dysfunction in walking myelodysplastic children. J Urol. 1992;148:362–5.

    CAS  PubMed  Google Scholar 

  57. Pontari MA, Keating M, Kelly MD, Dyro F, Bauer SB. Retained sacral function in children with high level myelodysplasia. J Urol. 1995;154:775–7.

    Article  CAS  PubMed  Google Scholar 

  58. Tarcan T, Bauer S, Olmedo E, Koshbin S, Kelly M, Darbey M. Long-term follow-up of newborns with myelodysplasia and normal urodynamic findings: is it necessary? J Urol. 2001;165:564–7.

    Article  CAS  PubMed  Google Scholar 

  59. Mandell J, Lebowitz RL, Hallett M, Khoshbin S, Bauer SB. Urethral narrowing in region of external sphincter: radiologic urodynamic correlations in boys with myelodysplasia. Am J Roentgenol. 1980;134:731–5.

    Article  CAS  Google Scholar 

  60. Bauer SB. The value of needle EMG in open and occult spinal dysraphisms. Vanderbilt Children’s Hospital Lecture. Accessed 6 Mar 2015.

    Google Scholar 

  61. Bauer SB. The management of the myelodysplastic child: a paradigm shift. BJU Int. 2003;92:23–8.

    Article  PubMed  Google Scholar 

  62. Rawashdeh YF, Austin P, Siggaard C, Bauer SB, Franco I, de Jong TP, et al. International Children’s Continence Society’s recommendations for therapeutic intervention in congenital neuropathic bladder and bowel dysfunction in children. Neurourol Urodyn. 2012;31:615–20.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology (Surgery), Harvard Medical School, Boston Children’s Hospital, 300 Longwood Avenue, Hunnewell 3rd Floor, Boston, MA, 02115, USA

    Stuart B. Bauer M.D.

Authors
  1. Stuart B. Bauer M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stuart B. Bauer M.D. .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, Georgetown University Medical Center, Washington, District of Columbia, USA

    Amin J. Barakat

  2. Division of Pediatric Urology, Children’, George Washington University School of M, Washington, District of Columbia, USA

    H. Gil Rushton

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Bauer, S.B. (2016). Congenital Neuropathic Bladder. In: Barakat, A., Rushton, H. (eds) Congenital Anomalies of the Kidney and Urinary Tract. Springer, Cham. https://doi.org/10.1007/978-3-319-29219-9_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-29219-9_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-29217-5

  • Online ISBN: 978-3-319-29219-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation